E-LIB Suche - Ergebnisse für: Cantilena, Sandra

1

FDA-approved disulfiram as a novel treatment for aggressive..:

Karsa, Mawar ; Xiao, Lin ; Ronca, Emma...
Journal of Molecular Medicine. 102 (2024) 4 - p. 507-519 , 2024

Link: https://doi.org/10.1007/..

2

A human genome editing–based MLL::AF4 ALL model recapitulat..:

Bueno, Clara ; Torres-Ruiz, Raul ; Velasco-Hernandez, Talia...
Blood. 142 (2023) 20 - p. 1752-1756 , 2023

Link: https://doi.org/10.1182/..

3

Direct targeted therapy for MLL‐fusion‐driven high‐risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
Clinical and Translational Medicine. 12 (2022) 6 - p. , 2022

Link: https://doi.org/10.1002/..

4

Identification of a c-MYB-directed therapeutic for acute my..:

Clesham, Katherine ; Walf-Vorderwülbecke, Vanessa ; Gasparoli, Luca...
Leukemia. 36 (2022) 6 - p. 1541-1549 , 2022

Link: https://doi.org/10.1038/..

5

Alcohol-abuse drug disulfiram targets pediatric glioma via ..:

Meier, Stefanie ; Cantilena, Sandra ; Niklison Chirou, Maria Victoria...
Cell Death & Disease. 12 (2021) 8 - p. , 2021

Link: https://doi.org/10.1038/..

6

Pre‐Clinical Evaluation of Drug Induced Proteolysis of MLL‐..:

Looi-Somoye, Remi ; Cantilena, Sandra ; de Boer, Jasper
The FASEB Journal. 34 (2020) S1 - p. 1-1 , 2020

Link: https://doi.org/10.1096/..

7

Physical Interaction between MYCN Oncogene and Polycomb Rep..:

Corvetta, Daisy ; Chayka, Olesya ; Gherardi, Samuele...
Journal of Biological Chemistry. 288 (2013) 12 - p. 8332-8341 , 2013

Link: https://doi.org/10.1074/..

8

A chemical screen identifies the chemotherapeutic drug topo..:

Sottile, Francesco ; Gnemmi, Ilaria ; Cantilena, Sandra..
Oncotarget. 3 (2012) 5 - p. 535-545 , 2012

Link: https://doi.org/10.18632..

9

Frizzled receptor 6 marks rare, highly tumourigenic stem-li..:

Cantilena, Sandra ; Pastorino, Fabio ; Pezzolo, Annalisa...
Oncotarget. 2 (2011) 12 - p. 976-983 , 2011

Link: https://doi.org/10.18632..

10

Addiction of MYCN Amplified Tumours to B-MYB Underscores a ..:

Gualdrini, Francesco ; Corvetta, Daisy ; Cantilena, Sandra...
Oncotarget. 1 (2010) 4 - p. 278-288 , 2010

Link: https://doi.org/10.18632..

11

Atherosclerotic intralesional haemorrhage moulds monocyte d..:

Boyle, Joseph J ; Philippidis, Pandelis ; Horncastle, Donna...
The FASEB Journal. 22 (2008) S1 - p. , 2008

Link: https://doi.org/10.1096/..

12

A flow cytometry procedure for simultaneous characterizatio..:

Lanuti, Paola ; Marchisio, Marco ; Cantilena, Sandra...
Journal of Immunological Methods. 315 (2006) 1-2 - p. 37-48 , 2006

Link: https://doi.org/10.1016/..

13

A human genome editing-based MLL::AF4 B-cell ALL model reca..:

Bueno, Clara ; Torres-Ruíz, Raul ; Velasco-Hernandez, Talia...
https://discovery.ucl.ac.uk/id/eprint/10178148/1/blood.2023020858.pdf. , 2023

Link: https://discovery.ucl.ac..

14

Direct targeted therapy for MLL-fusion-driven high-risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
https://www.repository.cam.ac.uk/handle/1810/339424. , 2022

Link: https://www.repository.c..

15

Identification of a c-MYB-directed therapeutic for acute my..:

Clesham, Katherine ; Walf-Vorderwülbecke, Vanessa ; Gasparoli, Luca...
Clesham , K , Walf-Vorderwülbecke , V , Gasparoli , L , Virely , C , Cantilena , S , Tsakaneli , A , Inglott , S , Adams , S , Samarasinghe , S , Bartram , J , Williams , G , de Boer , J & Williams , O 2022 , ' Identification of a c-MYB-directed therapeutic for acute myeloid leukemia ' , Leukemia , vol. 36 , no. 6 , pp. 1541-1549 . https://doi.org/10.1038/s41375-022-01554-9. , 2022

Link: https://kclpure.kcl.ac.u..